Costs of treating lower respiratory tract infections in outpatients

American Journal of Managed Care

Volumn 14, Issue 4, 2008, Pages 190-196

  Monte, Scott V ^a   Paolini, Nicole M ^b   Slazak, Erin M ^b   Schentag, Jerome J ^a   Paladino, Joseph A ^a  

^a CPL Associates LLC   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; COTRIMOXAZOLE; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ADULT; ARTICLE; CHRONIC BRONCHITIS; COMMUNITY ACQUIRED PNEUMONIA; COST BENEFIT ANALYSIS; DATA BASE; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG COST; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTERNATIONAL CLASSIFICATION OF DISEASES; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTPATIENT; PATHOLOGY; PRIORITY JOURNAL; RADIOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BRONCHITIS, CHRONIC; COMMUNITY-ACQUIRED INFECTIONS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 41849141617     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Harten W, Murt HA, Thomas WJ, et al. Incidence, utilization and costs associated with acute respiratory conditions United States, 1980. National Medical Care Utilization and Expenditure Survey. Series C, Analytical Report No. 4. Hyattsville, Md: National Center for Health Statistics; September 1986. DHHS publication 86-20404.
2. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998;20(4):820-837.
3. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther. 1999;21(3):576-591.
4. Dresser LD, Niederman MS, Paladino JA. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community acquired pneumonia. Chest. 2001;119(5):1439-1448.
5. Paladino JA, Gudgel LD, Forrest A, Niederman MS. Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs. cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. Chest. 2002;122(4):1271-1279.
6. Colice GL, Morley MA, Asche C, Birnbaum HG. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004;125(6):2140-2145.
7. Wilson L, Devine B, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med. 2000;94(3):204-213.
8. US Department of Labor, Bureau of Labor Statistics. Medical care consumer price index. http://www.bls.gov/cpi/home.htm. Accessed November 30, 2007.
9. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: US Department of Health and Human Services; 1996.
10. Anthonisen NR, Manfreda J, Warren CP, Harshfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204.
11. Marrie TJ. Community-acquired pneumonia: epidemiology, etiology, treatment. Infect Dis Clin North Am. 1998;12(3):723-740.
12. Meyer KC. Lung infections and aging. Ageing Res Rev. 2004;3(1):55-67.
13. Meyer KC. Pneumonia: predisposing factors, prevention and treatment. Geriatr Times. 2004;505(5):12-18.
14. Hak E, Rovers MM, Kuyvenhoven MM, Schellevis FG, Verheij TJ. Incidence of GP-diagnosed respiratory tract infections according to age, gender and high-risk co-morbidity: the second Dutch national survey of general practice. Fam Pract. 2006;23(3):291-294. Epub 2006 Feb 7.
15. Blasi F, Santiago E, Torres A, Huchon G. A review of guidelines for antibacterial use in acute exacerbations of chronic bronchitis. Pulm Pharmacol Ther. 2006;19(5):361-369.
16. American Thoracic Society and European Respiratory Society. Standards for the diagnosis and management of patients with COPD. 2004. http://www.thoracic.org/sections/copd. Accessed July 15, 2006.
17. Mandell L, Wunderink RG, Anzueto A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):527-572.
18. Whittle J, Fine MJ, Joyce DZ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual. 1997 Winter;12(4):187-193.